Write For Us

Breast cancer drug may also work against form of leukemia


Bone marrow myeloblasts are seen in acute myeloid leukemia. A new drug used for advanced breast cancer can work effectively to treat the form of leukemia, according to a study with mice and cells in a lab

By Allen Cone, UPI

A new drug used for advanced breast cancer can also work effectively to treat acute myeloid leukemia, according to a study with mice and cells in a lab.

Researchers at Newcastle University in London identified palbociclib for targeting the form of leukemia, but without the significant side effects, including irreversible heart damage and hair loss, unlike current chemotherapy. The findings were published Tuesday in the journal Cancer Cell.

Palbociclib is sold under the brand name Ibrance by Pfizer.

"Our discovery that this treatment can be effective in AML is an important step towards a more effective and less toxic treatment for patients with this form of leukaemia," study leader Dr. Olaf Heidenreich, of the Wolfson Childhood Cancer Research Center at Newcastle University, said in a press release. "This discovery will help advance treatment without severely impairing patients' quality of life."

Acute myeloid leukemia is characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood, and interfere with normal blood cells. The disease is uncommon before the age of 45, according to the American Cancer Society.

Based on data collected between 2008 and 2014, the five-year survival rate for the disease is 27.4 percent, and the National Cancer Institute estimates about 10,670 deaths will result from it this year.

In 2017, the U.S. Food and Drug Administration approved a tablet form of palbociclib for use to stop the spread of breast cancer in terminally ill patients for up to two years.

The treatment stops tumors from growing by preventing key molecules of cell cycle progression.

Scientists at Newcastle and the University of Birmingham performed genomic analysis on AML cells and identified two key molecules involved in the progression of leukemia: CDK6 and CCND2.

"We are now carrying out research to identify combinations of medicines containing palbociclib that will effectively eradicate AML without causing substantial therapy-associated 'collateral damage,' " Olaf said.


Note: If you think this story need more information or correction, feel free to comment below your opinion and reaction.
Like & Follow to Stay Updated ...


Body & Mind,3,Fitness,20,Health,1450,Weight Loss,3,Wellness,2,
Health - U.S. Daily News: Breast cancer drug may also work against form of leukemia
Breast cancer drug may also work against form of leukemia
Health - U.S. Daily News
Loaded All Posts Not found any posts VIEW ALL Read More Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share. STEP 2: Click the link you shared to unlock Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy